Global Medullary Thyroid Cancer Drugs Sales Market Report 2017

January 2017 | 103 pages | ID: GCE3EE9E5BFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Medullary Thyroid Cancer Drugs

Revenue, means the sales value of Medullary Thyroid Cancer Drugs

This report studies sales (consumption) of Medullary Thyroid Cancer Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Sinofi Genzyme
• Exelixis

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Medullary Thyroid Cancer Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Caprelsa
• Cabozantinib

Split by applications, this report focuses on sales, market share and growth rate of Medullary Thyroid Cancer Drugs in each application, can be divided into

• Collection
• Packing
• Others

Contents

Global Medullary Thyroid Cancer Drugs Sales Market Report 2017

1 MEDULLARY THYROID CANCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Medullary Thyroid Cancer Drugs
1.2 Classification of Medullary Thyroid Cancer Drugs
  1.2.1 Caprelsa
  1.2.2 Cabozantinib
1.3 Application of Medullary Thyroid Cancer Drugs
  1.3.1 Collection
  1.3.2 Packing
  1.3.3 Others
1.4 Medullary Thyroid Cancer Drugs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Medullary Thyroid Cancer Drugs (2011-2021)
  1.5.1 Global Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL MEDULLARY THYROID CANCER DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Medullary Thyroid Cancer Drugs Market Competition by Manufacturers
  2.1.1 Global Medullary Thyroid Cancer Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Medullary Thyroid Cancer Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Medullary Thyroid Cancer Drugs (Volume and Value) by Type
  2.2.1 Global Medullary Thyroid Cancer Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Medullary Thyroid Cancer Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Medullary Thyroid Cancer Drugs (Volume and Value) by Regions
  2.3.1 Global Medullary Thyroid Cancer Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Medullary Thyroid Cancer Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Medullary Thyroid Cancer Drugs (Volume) by Application

3 UNITED STATES MEDULLARY THYROID CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Medullary Thyroid Cancer Drugs Sales and Value (2011-2016)
  3.1.1 United States Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
  3.1.2 United States Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
3.2 United States Medullary Thyroid Cancer Drugs Sales and Market Share by Manufacturers
3.3 United States Medullary Thyroid Cancer Drugs Sales and Market Share by Type
3.4 United States Medullary Thyroid Cancer Drugs Sales and Market Share by Application

4 CHINA MEDULLARY THYROID CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Medullary Thyroid Cancer Drugs Sales and Value (2011-2016)
  4.1.1 China Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
4.2 China Medullary Thyroid Cancer Drugs Sales and Market Share by Manufacturers
4.3 China Medullary Thyroid Cancer Drugs Sales and Market Share by Type
4.4 China Medullary Thyroid Cancer Drugs Sales and Market Share by Application

5 EUROPE MEDULLARY THYROID CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Medullary Thyroid Cancer Drugs Sales and Value (2011-2016)
  5.1.1 Europe Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
5.2 Europe Medullary Thyroid Cancer Drugs Sales and Market Share by Manufacturers
5.3 Europe Medullary Thyroid Cancer Drugs Sales and Market Share by Type
5.4 Europe Medullary Thyroid Cancer Drugs Sales and Market Share by Application

6 JAPAN MEDULLARY THYROID CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Medullary Thyroid Cancer Drugs Sales and Value (2011-2016)
  6.1.1 Japan Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
6.2 Japan Medullary Thyroid Cancer Drugs Sales and Market Share by Manufacturers
6.3 Japan Medullary Thyroid Cancer Drugs Sales and Market Share by Type
6.4 Japan Medullary Thyroid Cancer Drugs Sales and Market Share by Application

7 SOUTHEAST ASIA MEDULLARY THYROID CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Medullary Thyroid Cancer Drugs Sales and Value (2011-2016)
  7.1.1 Southeast Asia Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Southeast Asia Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
  7.1.3 Southeast Asia Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
7.2 Southeast Asia Medullary Thyroid Cancer Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Medullary Thyroid Cancer Drugs Sales and Market Share by Type
7.4 Southeast Asia Medullary Thyroid Cancer Drugs Sales and Market Share by Application

8 INDIA MEDULLARY THYROID CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Medullary Thyroid Cancer Drugs Sales and Value (2011-2016)
  8.1.1 India Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
  8.1.2 India Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
  8.1.3 India Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
8.2 India Medullary Thyroid Cancer Drugs Sales and Market Share by Manufacturers
8.3 India Medullary Thyroid Cancer Drugs Sales and Market Share by Type
8.4 India Medullary Thyroid Cancer Drugs Sales and Market Share by Application

9 GLOBAL MEDULLARY THYROID CANCER DRUGS MANUFACTURERS ANALYSIS

9.1 Sinofi Genzyme
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Medullary Thyroid Cancer Drugs Product Type, Application and Specification
    9.1.2.1 Caprelsa
    9.1.2.2 Cabozantinib
  9.1.3 Sinofi Genzyme Medullary Thyroid Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Exelixis
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Medullary Thyroid Cancer Drugs Product Type, Application and Specification
    9.2.2.1 Caprelsa
    9.2.2.2 Cabozantinib
  9.2.3 Exelixis Medullary Thyroid Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview

10 MEDULLARY THYROID CANCER DRUGS MAUFACTURING COST ANALYSIS

10.1 Medullary Thyroid Cancer Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Medullary Thyroid Cancer Drugs
10.3 Manufacturing Process Analysis of Medullary Thyroid Cancer Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Medullary Thyroid Cancer Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Medullary Thyroid Cancer Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL MEDULLARY THYROID CANCER DRUGS MARKET FORECAST (2016-2021)

14.1 Global Medullary Thyroid Cancer Drugs Sales, Revenue and Price Forecast (2016-2021)
  14.1.1 Global Medullary Thyroid Cancer Drugs Sales and Growth Rate Forecast (2016-2021)
  14.1.2 Global Medullary Thyroid Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
  14.1.3 Global Medullary Thyroid Cancer Drugs Price and Trend Forecast (2016-2021)
14.2 Global Medullary Thyroid Cancer Drugs Sales, Revenue and Growth Rate Forecast by Regions (2016-2021)
  14.2.1 United States Medullary Thyroid Cancer Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.2 China Medullary Thyroid Cancer Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.3 Europe Medullary Thyroid Cancer Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.4 Japan Medullary Thyroid Cancer Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.5 Southeast Asia Medullary Thyroid Cancer Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.6 India Medullary Thyroid Cancer Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
14.3 Global Medullary Thyroid Cancer Drugs Sales, Revenue and Price Forecast by Type (2016-2021)
14.4 Global Medullary Thyroid Cancer Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Medullary Thyroid Cancer Drugs
Table Classification of Medullary Thyroid Cancer Drugs
Figure Global Sales Market Share of Medullary Thyroid Cancer Drugs by Type in 2015
Figure Caprelsa Picture
Figure Cabozantinib Picture
Table Applications of Medullary Thyroid Cancer Drugs
Figure Global Sales Market Share of Medullary Thyroid Cancer Drugs by Application in 2015
Figure Collection Examples
Figure Packing Examples
Figure Others Examples
Figure United States Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure China Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure India Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure Global Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2021)
Figure Global Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2021)
Table Global Medullary Thyroid Cancer Drugs Sales of Key Manufacturers (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Medullary Thyroid Cancer Drugs Sales Share by Manufacturers
Figure 2016 Medullary Thyroid Cancer Drugs Sales Share by Manufacturers
Table Global Medullary Thyroid Cancer Drugs Revenue by Manufacturers (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Medullary Thyroid Cancer Drugs Revenue Share by Manufacturers
Table 2016 Global Medullary Thyroid Cancer Drugs Revenue Share by Manufacturers
Table Global Medullary Thyroid Cancer Drugs Sales and Market Share by Type (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Medullary Thyroid Cancer Drugs by Type (2011-2016)
Figure Global Medullary Thyroid Cancer Drugs Sales Growth Rate by Type (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Revenue and Market Share by Type (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Medullary Thyroid Cancer Drugs by Type (2011-2016)
Figure Global Medullary Thyroid Cancer Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Sales and Market Share by Regions (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Medullary Thyroid Cancer Drugs by Regions (2011-2016)
Figure Global Medullary Thyroid Cancer Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Medullary Thyroid Cancer Drugs by Regions (2011-2016)
Figure Global Medullary Thyroid Cancer Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Sales and Market Share by Application (2011-2016)
Table Global Medullary Thyroid Cancer Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Medullary Thyroid Cancer Drugs by Application (2011-2016)
Figure Global Medullary Thyroid Cancer Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
Figure United States Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure United States Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Sales by Manufacturers (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Market Share by Manufacturers (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Sales by Type (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Market Share by Type (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Sales by Application (2011-2016)
Table United States Medullary Thyroid Cancer Drugs Market Share by Application (2011-2016)
Figure China Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
Figure China Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure China Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
Table China Medullary Thyroid Cancer Drugs Sales by Manufacturers (2011-2016)
Table China Medullary Thyroid Cancer Drugs Market Share by Manufacturers (2011-2016)
Table China Medullary Thyroid Cancer Drugs Sales by Type (2011-2016)
Table China Medullary Thyroid Cancer Drugs Market Share by Type (2011-2016)
Table China Medullary Thyroid Cancer Drugs Sales by Application (2011-2016)
Table China Medullary Thyroid Cancer Drugs Market Share by Application (2011-2016)
Figure Europe Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
Figure Europe Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
Table Europe Medullary Thyroid Cancer Drugs Sales by Manufacturers (2011-2016)
Table Europe Medullary Thyroid Cancer Drugs Market Share by Manufacturers (2011-2016)
Table Europe Medullary Thyroid Cancer Drugs Sales by Type (2011-2016)
Table Europe Medullary Thyroid Cancer Drugs Market Share by Type (2011-2016)
Table Europe Medullary Thyroid Cancer Drugs Sales by Application (2011-2016)
Table Europe Medullary Thyroid Cancer Drugs Market Share by Application (2011-2016)
Figure Japan Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
Figure Japan Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
Table Japan Medullary Thyroid Cancer Drugs Sales by Manufacturers (2011-2016)
Table Japan Medullary Thyroid Cancer Drugs Market Share by Manufacturers (2011-2016)
Table Japan Medullary Thyroid Cancer Drugs Sales by Type (2011-2016)
Table Japan Medullary Thyroid Cancer Drugs Market Share by Type (2011-2016)
Table Japan Medullary Thyroid Cancer Drugs Sales by Application (2011-2016)
Table Japan Medullary Thyroid Cancer Drugs Market Share by Application (2011-2016)
Figure Southeast Asia Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
Figure Southeast Asia Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
Table Southeast Asia Medullary Thyroid Cancer Drugs Sales by Manufacturers (2011-2016)
Table Southeast Asia Medullary Thyroid Cancer Drugs Market Share by Manufacturers (2011-2016)
Table Southeast Asia Medullary Thyroid Cancer Drugs Sales by Type (2011-2016)
Table Southeast Asia Medullary Thyroid Cancer Drugs Market Share by Type (2011-2016)
Table Southeast Asia Medullary Thyroid Cancer Drugs Sales by Application (2011-2016)
Table Southeast Asia Medullary Thyroid Cancer Drugs Market Share by Application (2011-2016)
Figure India Medullary Thyroid Cancer Drugs Sales and Growth Rate (2011-2016)
Figure India Medullary Thyroid Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure India Medullary Thyroid Cancer Drugs Sales Price Trend (2011-2016)
Table India Medullary Thyroid Cancer Drugs Sales by Manufacturers (2011-2016)
Table India Medullary Thyroid Cancer Drugs Market Share by Manufacturers (2011-2016)
Table India Medullary Thyroid Cancer Drugs Sales by Type (2011-2016)
Table India Medullary Thyroid Cancer Drugs Market Share by Type (2011-2016)
Table India Medullary Thyroid Cancer Drugs Sales by Application (2011-2016)
Table India Medullary Thyroid Cancer Drugs Market Share by Application (2011-2016)
Table Sinofi Genzyme Basic Information List
Table Sinofi Genzyme Medullary Thyroid Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sinofi Genzyme Medullary Thyroid Cancer Drugs Global Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Medullary Thyroid Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Exelixis Medullary Thyroid Cancer Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Medullary Thyroid Cancer Drugs
Figure Manufacturing Process Analysis of Medullary Thyroid Cancer Drugs
Figure Medullary Thyroid Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Medullary Thyroid Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Medullary Thyroid Cancer Drugs
Table Distributors/Traders List
Figure Global Medullary Thyroid Cancer Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Medullary Thyroid Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Medullary Thyroid Cancer Drugs Sales Forecast by Regions (2016-2021)
Table Global Medullary Thyroid Cancer Drugs Sales Forecast by Type (2016-2021)
Table Global Medullary Thyroid Cancer Drugs Sales Forecast by Application (2016-2021)